Latest Verisante Technology Inc (VRSEF) Headlines
Verisante Technology, Inc. Grows Sales and Marketing Team
Marketwire - Wed Feb 26, 9:02AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that the Company has hired Jason Mangler as Director of Sales to guide the Company's world-wide sales and marketing strategy. Verisante has also hired Kim Ellis, as the Company's Sales Representative for Western Canada.
Launch: Ericsson brings capacity with 'Small Cell as a Service'
M2 - Thu Feb 13, 7:16AM CST
- Enables increased network capacity in environments where large numbers of people gather and consume large amounts of data
Verisante Technology, Inc. Launches New Product at SPIE Photonics West 2014 in San Francisco, CA
Marketwire - Tue Feb 04, 8:31AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that the Company is launching a new product at the SPIE Photonics West 2014 industry exhibit in San Francisco, California from February 4-6, 2014. Photonics West is the annual flagship event for the optics and photonics industry, with 20,000 attendees expected to attend.
A.M. Best Affirms Ratings of LocalTapiola General Mutual Insurance Company
A.M. Best Company - AMBest - Fri Jan 17, 10:41AM CST
A.M. Best Europe â?? Rating Services Limited has affirmed the financial strength rating of A (Excellent) and issuer credit rating of â??aâ? of LocalTapiola General Mutual Insurance Company (LocalTapiola) (Finland). The outlook for both ratings remains stable.
Verisante Technology, Inc. Announces 2013 Third Quarter Results and Plans for Direct Distribution in Canada
Marketwire - Thu Nov 28, 12:58PM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: RSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that the Company has released its financial results for the third quarter ended September 30, 2013.
BTV-Business Television - Verisante Technology Innovation for the Early Detection of Skin Cancer
Newsfile Corp - Fri Nov 08, 6:34PM CST
full story)
Verisante Technology, Inc. Closes Prospectus Offering
Marketwire - Fri Nov 08, 12:54PM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF)(FRANKFURT: V3T) (the "Company" or "Verisante"), a leader in cancer detection technology, today announced closing of its previously announced commercially reasonably efforts public offering of units ("Units") pursuant to a short form base shelf prospectus (the "Offering"). The Offering was conducted by Jordan Capital Markets Inc. (the "Agent"). Each Unit was priced at $0.19 and consisted of one common share of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant"). Each Warrant is exercisable to acquire one Common Share at a price of $0.25 until November 8, 2015, subject to certain acceleration provisions contained within the warrant certificate.
BTV-Business Television Rising Stars in Life Sciences with Verisante, Vivione, biOasis, Theralase and Aurora Spine
GlobeNewswire - Thu Nov 07, 3:11PM CST
via PRWEB - On BNN and FOX Business News Network on Sun Nov. 10th, 2013 - on National TV, BTV-Business Television highlights the following companies:
Verisante Technology, Inc. Files Prospectus Supplement
Newsfile Corp - Fri Oct 11, 4:05PM CDT
full story)
Verisante Technology, Inc. Files Preliminary Short Form Base Shelf Prospectus
Newsfile Corp - Fri Sep 13, 6:12PM CDT
full story)
Verisante Technology, Inc. Announces Completion of Prototype of Multispectral Imaging System for Skin Cancer
Marketwire - Tue Sep 10, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that the Company has completed the second phase prototype of a rapid Multispectral Imaging ("MSI") System for skin cancer detection.
Verisante Technology, Inc. Announces 2013 Second Quarter Results and Reports on Progress with Core Device for Lung, Colon and Nasopharyngeal Cancer
Marketwire - Fri Aug 30, 8:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that the Company has released its financial results for the second quarter ended June 30, 2013 .
Verisante Technology, Inc. Grows Sales and Marketing Team
Marketwire - Wed Feb 26, 9:02AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that the Company has hired Jason Mangler as Director of Sales to guide the Company's world-wide sales and marketing strategy. Verisante has also hired Kim Ellis, as the Company's Sales Representative for Western Canada.
Launch: Ericsson brings capacity with 'Small Cell as a Service'
M2 - Thu Feb 13, 7:16AM CST
- Enables increased network capacity in environments where large numbers of people gather and consume large amounts of data
Verisante Technology, Inc. Launches New Product at SPIE Photonics West 2014 in San Francisco, CA
Marketwire - Tue Feb 04, 8:31AM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that the Company is launching a new product at the SPIE Photonics West 2014 industry exhibit in San Francisco, California from February 4-6, 2014. Photonics West is the annual flagship event for the optics and photonics industry, with 20,000 attendees expected to attend.
A.M. Best Affirms Ratings of LocalTapiola General Mutual Insurance Company
A.M. Best Company - AMBest - Fri Jan 17, 10:41AM CST
A.M. Best Europe â?? Rating Services Limited has affirmed the financial strength rating of A (Excellent) and issuer credit rating of â??aâ? of LocalTapiola General Mutual Insurance Company (LocalTapiola) (Finland). The outlook for both ratings remains stable.
Verisante Technology, Inc. Announces 2013 Third Quarter Results and Plans for Direct Distribution in Canada
Marketwire - Thu Nov 28, 12:58PM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: RSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that the Company has released its financial results for the third quarter ended September 30, 2013.
BTV-Business Television - Verisante Technology Innovation for the Early Detection of Skin Cancer
Newsfile Corp - Fri Nov 08, 6:34PM CST
full story)
Verisante Technology, Inc. Closes Prospectus Offering
Marketwire - Fri Nov 08, 12:54PM CST
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF)(FRANKFURT: V3T) (the "Company" or "Verisante"), a leader in cancer detection technology, today announced closing of its previously announced commercially reasonably efforts public offering of units ("Units") pursuant to a short form base shelf prospectus (the "Offering"). The Offering was conducted by Jordan Capital Markets Inc. (the "Agent"). Each Unit was priced at $0.19 and consisted of one common share of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant"). Each Warrant is exercisable to acquire one Common Share at a price of $0.25 until November 8, 2015, subject to certain acceleration provisions contained within the warrant certificate.
BTV-Business Television Rising Stars in Life Sciences with Verisante, Vivione, biOasis, Theralase and Aurora Spine
GlobeNewswire - Thu Nov 07, 3:11PM CST
via PRWEB - On BNN and FOX Business News Network on Sun Nov. 10th, 2013 - on National TV, BTV-Business Television highlights the following companies:
Verisante Technology, Inc. Files Prospectus Supplement
Newsfile Corp - Fri Oct 11, 4:05PM CDT
full story)
Verisante Technology, Inc. Files Preliminary Short Form Base Shelf Prospectus
Newsfile Corp - Fri Sep 13, 6:12PM CDT
full story)
Verisante Technology, Inc. Announces Completion of Prototype of Multispectral Imaging System for Skin Cancer
Marketwire - Tue Sep 10, 9:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that the Company has completed the second phase prototype of a rapid Multispectral Imaging ("MSI") System for skin cancer detection.
Verisante Technology, Inc. Announces 2013 Second Quarter Results and Reports on Progress with Core Device for Lung, Colon and Nasopharyngeal Cancer
Marketwire - Fri Aug 30, 8:01AM CDT
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today that the Company has released its financial results for the second quarter ended June 30, 2013 .
